✦ LIBER ✦

Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response

✍ Scribed by Peter Ferenci; Hermann Laferl; Thomas–Matthias Scherzer; Michael Gschwantler; Andreas Maieron; Harald Brunner; Rudolf Stauber; Martin Bischof; Bernhard Bauer; Christian Datz; Karin Löschenberger; Elisabeth Formann; Katharina Staufer; Petra Steindl–Munda

Book ID: 119760384
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 263 KB
Volume: 135
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2008.04.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon Alfa-2a/Ribavirin for 48 o

Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response

✍ Peter Ferenci; Hermann Laferl; Thomas–Matthias Scherzer; Andreas Maieron; Harald 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 1020 KB

Prediction of sustained virological resp

Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin

✍ Foster, Graham R.; Fried, Michael W.; Hadziyannis, Stephanos J.; Messinger, Diet 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 392 KB

Pegylated interferon alfa and ribavirin

Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

✍ Olav Dalgard; Kristian Bjøro; Helmer Ring-Larsen; Einar Bjornsson; Mona Holberg- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

A recent nonrandomized pilot trial showed that hepatitis C virus (HCV) patients with genotype 2/3 and rapid virological response (RVR) had a 90% sustained virological response (SVR) rate after 14 weeks of treatment. We aimed to assess this concept in a randomized controlled trial. In the trial, 428

Predicting sustained virological respons

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Randomized trial of peginterferon alfa-2

Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virological response

✍ Brian L. Pearlman; Carole Ehleben 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 2 views

746 NARLAPREVIR AND PEGINTERFERON ALFA-2

746 NARLAPREVIR AND PEGINTERFERON ALFA-2B FOR 2 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS, FOLLOWED BY PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR 24/48 WEEKS: FINAL RESULTS

✍ J. de Bruijne; J.F. Bergmann; C.J. Weegink; R. Molenkamp; J. Schinkel; M.A. Trei 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 69 KB